Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ENSC

Ensysce Biosciences (ENSC) stock: insider trades, news & valuation

Health Care · Net buying
Close · Oct 9, 2026 $0.53 +15.1% on the day -77.4% over 12 months 52-week range $0.25 – $2.57

Share price and insider trades

ENSC closeInsider buyInsider sale
0123NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $200,000 on 2026-08-07 · Bob G GowerBought $244,135 on 2026-04-23 · Bob G Gower
Bought, 12 months$444K
Sold, 12 months$0
Insiders buying1
Insiders selling0

Ensysce Biosciences insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $444K and 0 sold $0 of ENSC stock on the open market.

ENSC insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $244K bought (1 trades)$244KQ2 2026Q3 2026: $200K bought (1 trades)$200KQ3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026$200K1—0
Q2 2026$244K1—0

Valuation, profit and volume

P/E (trailing)n/aSector median 24.7
Market value$10.3MBiotechnology
Profit margin-280.5%Revenue growth -15.1%
Volume vs. 50-day0.1×Last 5 sessions
Insiders' paper profit+$35KOn all tracked purchases +7.8%

Summary

Over the past 12 months, 1 Ensysce Biosciences, Inc. insider reported open-market purchases totaling $444K, while 0 insiders reported sales totaling $0.

ENSC stock news and SEC filings

Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Aug 18SEC Bob G GowerDirector Buy 508,614516,740 held (+6259%) $0.48 $244K +9.8% —
Aug 18SEC Bob G GowerDirector Buy 400,000916,740 held (+77%) $0.50 $200K +5.4% —

Insiders at Ensysce Biosciences, Inc.

InsiderBoughtSoldLast filingScore
Bob G GowerDirector $444K — Aug 18, 2026 —

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • SLBTSL Science Holding Ltd$10329.90B bought
  • KODKodiak Sciences Inc.$157M bought
  • ADRXADARx Pharmaceuticals, Inc.$87.7M bought
  • ATTOAttovia Therapeutics, Inc.$72.9M bought
  • MPLTMapLight Therapeutics, Inc.$65.5M bought
  • AVRAnteris Technologies Global Corp.$40.4M bought

ENSC stock: common questions

Are Ensysce Biosciences, Inc. insiders buying ENSC stock?

In the past 12 months, 1 insiders reported open-market purchases of ENSC worth $444K. The latest was Director Bob G Gower bought $244K of ENSC at $0.48 — first open-market purchase in our records; raises the stake by 6259%.

Are Ensysce Biosciences, Inc. insiders selling ENSC stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ENSC's 52-week range?

Over the past year ENSC has traded between $0.25 and $2.57. It last closed at $0.53 on Oct 9, 2026.